Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Pacira BioSciences (NASDAQ: PCRX) has announced its upcoming presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Wednesday, January 15, 2025, at 10:30 AM PT (1:30 PM EST).
Interested parties can access the live audio presentation through the 'Events' page on the company's investor website at investor.pacira.com. The company will make a replay of the webcast available for a two-week period following the event.
Pacira BioSciences (NASDAQ: PCRX) ha annunciato la sua prossima presentazione alla 43ª Conferenza Annuale sulla Salute J.P. Morgan. La presentazione è programmata per mercoledì 15 gennaio 2025, alle 10:30 AM PT (1:30 PM EST).
Le parti interessate possono accedere alla presentazione audio dal vivo attraverso la pagina 'Eventi' sul sito web per investitori della compagnia all'indirizzo investor.pacira.com. La società renderà disponibile una registrazione del webcast per un periodo di due settimane dopo l'evento.
Pacira BioSciences (NASDAQ: PCRX) ha anunciado su próxima presentación en la 43ª Conferencia Anual de Salud J.P. Morgan. La presentación está programada para miércoles 15 de enero de 2025, a las 10:30 AM PT (1:30 PM EST).
Las partes interesadas pueden acceder a la presentación de audio en vivo a través de la página 'Eventos' en el sitio web para inversores de la compañía en investor.pacira.com. La compañía hará disponible una repetición de la transmisión durante un período de dos semanas después del evento.
Pacira BioSciences (NASDAQ: PCRX)는 제43회 연례 J.P. 모건 헬스케어 컨퍼런스에서 발표할 예정이라고 발표했습니다. 발표는 2025년 1월 15일 수요일 오전 10:30 PT (오후 1:30 EST)로 예정되어 있습니다.
관심 있는 분들은 회사 투자자 웹사이트의 '이벤트' 페이지를 통해 실시간 오디오 발표에 액세스할 수 있습니다. 회사는 이벤트 이후 2주 동안 웹캐스트 재생을 제공할 예정입니다.
Pacira BioSciences (NASDAQ: PCRX) a annoncé sa prochaine présentation lors de la 43ème Conférence Annuelle J.P. Morgan sur la Santé. La présentation est prévue pour mercredi 15 janvier 2025, à 10h30 PT (13h30 EST).
Les parties intéressées peuvent accéder à la présentation audio en direct via la page 'Événements' du site des investisseurs de l'entreprise à l'adresse investor.pacira.com. L'entreprise mettra à disposition une rediffusion du webcast pendant une période de deux semaines après l'événement.
Pacira BioSciences (NASDAQ: PCRX) hat seine bevorstehende Präsentation auf der 43. J.P. Morgan Healthcare-Konferenz angekündigt. Die Präsentation ist für Mittwoch, den 15. Januar 2025, um 10:30 Uhr PT (13:30 Uhr EST) angesetzt.
Interessierte Parteien können die Live-Audio-Präsentation über die 'Veranstaltungen'-Seite der Investor-Website des Unternehmens unter investor.pacira.com abrufen. Das Unternehmen wird eine Wiederholung des Webcasts für einen Zeitraum von zwei Wochen nach der Veranstaltung zur Verfügung stellen.
- None.
- None.
PARSIPPANY, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference at 10:30 AM PT (1:30 PM EST) on Wednesday, January 15, 2025. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.
About Pacira
Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing the development of PCRX-201, a novel locally administered gene therapy with the potential to treat large prevalent diseases like osteoarthritis. To learn more about Pacira, visit www.pacira.com.
FAQ
When is Pacira BioSciences (PCRX) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Pacira BioSciences' (PCRX) J.P. Morgan Healthcare Conference presentation?
How long will the replay of PCRX's J.P. Morgan Healthcare Conference presentation be available?
Which annual J.P. Morgan Healthcare Conference is Pacira BioSciences (PCRX) participating in?
